Innovative Hand-Held Insulin Device Effectively Controls Diabetes and Provides Reliable and Easy to Use Insulin Dosing
January 28, 2006 Pfizer’s Exubera (insulin human [rDNA origin]) Inhalation Powder has been approved by the U.S. Food and Drug Administration for the treatment of adults with type 1 and type 2 diabetes. Exubera was found in clinical trials to be as effective as short-acting insulin injections, and to significantly improve blood sugar control when added to diabetes pills. Exubera, which is expected to be available for patients by mid-year, is the first inhaled form of insulin and the first insulin option in the United States that does not need to be administered by injection. Pfizer is naturally hailing the new drug form as a breakthrough.
Other Images from this Gallery